Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 9, 2022
The Human Cost: Patient Contribution to Clinical Trials in NeurologyLauren B Reoma, Barbara Illowsky KarpContinuum (Minneapolis, Minn.)|December 20, 2022
The Practice of Experimental Neurotherapeutics in Neuromuscular DiseaseLauren B Reoma, Avindra Nath, Robert C GriggsJournal of Virology|November 8, 2019
Advances toward Curing HIV-1 Infection in Tissue ReservoirsLisa J Henderson, Lauren B Reoma, Joseph A Kovacs, et al.Clinical Case Reports|January 31, 2020
Neurotoxicities associated with checkpoint inhibitors: Two case reports and a review of the literatureLisa M Cordes, Nicole N Davarpanah, Lauren B Reoma, et al.Annals of Neurology|December 22, 2022
Experimental Neurotherapeutics: Surfing the Tidal Wave of New OpportunitiesLauren B Reoma, Ania Busza, M Maral Mouradian, et al.The New England Journal of Medicine|April 11, 2019
Pembrolizumab Treatment for Progressive Multifocal LeukoencephalopathyIrene Cortese, Pawel Muranski, Yoshimi Enose-Akahata, et al.Neurology(R) Neuroimmunology & Neuroinflammation|May 5, 2023
Deep Phenotyping of Neurologic Postacute Sequelae of SARS-CoV-2 InfectionYair Mina, Yoshimi Enose-Akahata, Dima A Hammoud, et al.The Journal of Infectious Diseases|March 9, 2026
Safety, immunovirological, and CNS effects of PD-1 inhibition in people with HIV without malignancyLauren B Reoma, Tory P Johnson, Ken Cheung, et al.Annals of Neurology|August 29, 2019
Chronic Dengue Virus Panencephalitis in a Patient with Progressive Dementia with Extrapyramidal FeaturesTory P Johnson, H Benjamin Larman, Myoung-Hwa Lee, et al.The Lancet. Infectious Diseases|August 10, 2020
STROBE-metagenomics: a STROBE extension statement to guide the reporting of metagenomics studiesTehmina Bharucha, Clarissa Oeser, Francois Balloux, et al.Pageof 2